Literature DB >> 3139203

Interferon for treatment.

A Galazka, E Scott.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3139203      PMCID： PMC1840351          DOI： 10.1136/bmj.297.6647.558-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Small cell lung carcinoma. A phase II evaluation of r-interferon-gamma.

Authors:  H F Newman; N M Bleehen; A Galazka; E Scott
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

2.  A phase 1 study of recombinant interferon-gamma given intravenously by portable mini-pump: a preliminary report.

Authors:  K Sriskandan; P Garner; J Watkinson; L Gerlis; D E Tee
Journal:  Int J Clin Pharmacol Res       Date:  1984

Review 3.  Gamma-interferon: physiology and speculation on its role in medicine.

Authors:  E M Bonnem; R K Oldham
Journal:  J Biol Response Mod       Date:  1987-06

4.  Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma.

Authors:  E M Lemmel; M Franke; W Gaus; P W Hartl; P H Hofschneider; K Miehlke; K Machalke; H J Obert
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

5.  Preventive of immunization in women at greatest risk using anti-Rh (D) gamma globulin.

Authors:  P W Robertson; B R Cooke
Journal:  Med J Aust       Date:  1969-06-07       Impact factor: 7.738

6.  Low-dose gamma interferon in treatment of rheumatoid arthritis.

Authors:  E M Lemmel; H J Obert; P H Hofschneider
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

7.  Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma.

Authors:  J M Parkin; L J Eales; A R Galazka; A J Pinching
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

8.  Exacerbations of multiple sclerosis in patients treated with gamma interferon.

Authors:  H S Panitch; R L Hirsch; A S Haley; K P Johnson
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

9.  Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.

Authors:  M van der Burg; M Edelstein; L Gerlis; C M Liang; M Hirschi; A Dawson
Journal:  J Biol Response Mod       Date:  1985-06

10.  Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma.

Authors:  M B Garnick; S D Reich; B Maxwell; S Coval-Goldsmith; J P Richie; S A Rudnick
Journal:  J Urol       Date:  1988-02       Impact factor: 7.450
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.